Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

(2021) Daniel Taliun et al.   NATURE

A globally diverse reference alignment and panel for imputation of mitochondrial DNA variants

(2021) Tim W. McInerney et al.   BMC BIOINFORMATICS

Circular RNA UBE2Q2 promotes malignant progression of gastric cancer by regulating signal transducer and activator of transcription 3-mediated autophagy and glycolysis

(2021) Jing Yang et al.   Cell Death & Disease

CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma

(2020) Xue-Tang Mo et al.   BRITISH JOURNAL OF CANCER

Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance

(2020) Alyssa I. Clay-Gilmour et al.   Blood Advances

Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma

(2019) Hauke Thomsen et al.   LEUKEMIA

Monoclonal gammopathy of undetermined significance (MGUS)

(2019) Tarek H Mouhieddine et al.   BLOOD

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

(2018) Molly Went et al.   Nature Communications

Mitochondria and Cancer

(2016) Sejal Vyas et al.   CELL

Next-generation genotype imputation service and methods

(2016) Sayantan Das et al.   NATURE GENETICS

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

(2016) Jonathan S. Mitchell et al.   Nature Communications

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

(2009) O. Landgren et al.   BLOOD

A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity

(2009) Daniela Sorriento et al.   Molecular Cancer